AnaptysBio, Inc. short interest in 2023
In 2023, AnaptysBio, Inc.'s disclosed short interest ran from 17.39% of shares outstanding on 13 Jan 2023 to 16.81% on 29 Dec 2023, a change of -0.58 percentage points. The year's high was 19.02% on 31 Oct 2023 and its low 14.76% on 31 Jan 2023, averaging 17.13% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 34.42 days on 31 May 2023. Full history: AnaptysBio, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 17.39% (13 Jan 2023)
- End of year
- 16.81% (29 Dec 2023)
- Change
- -0.58 pp
- High
- 19.02% (31 Oct 2023)
- Low
- 14.76% (31 Jan 2023)
- Average
- 17.13%
- Highest days to cover
- 34.42 (31 May 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 17.39% | 10.01 | results (8-K) |
| 31 Jan 2023 | 14.76% | 7.35 | |
| 15 Feb 2023 | 14.84% | 22.71 | |
| 28 Feb 2023 | 15.31% | 18.24 | |
| 15 Mar 2023 | 16.44% | 22.76 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 16.86% | 21.10 | |
| 14 Apr 2023 | 17.05% | 17.89 | |
| 28 Apr 2023 | 17.11% | 20.35 | |
| 15 May 2023 | 17.35% | 26.83 | 10-Q filed, results (8-K) |
| 31 May 2023 | 17.79% | 34.42 | |
| 15 Jun 2023 | 16.85% | 27.43 | |
| 30 Jun 2023 | 16.56% | 15.99 | |
| 14 Jul 2023 | 16.46% | 31.84 | |
| 31 Jul 2023 | 16.70% | 21.16 | |
| 15 Aug 2023 | 17.79% | 12.73 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 17.47% | 20.42 | |
| 15 Sep 2023 | 17.66% | 15.34 | |
| 29 Sep 2023 | 17.86% | 16.15 | |
| 13 Oct 2023 | 18.68% | 24.89 | |
| 31 Oct 2023 | 19.02% | 23.83 | |
| 15 Nov 2023 | 18.60% | 20.50 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 18.70% | 29.37 | |
| 15 Dec 2023 | 16.94% | 12.12 | |
| 29 Dec 2023 | 16.81% | 22.37 |
See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.